KRAS and pleural neoplasm: EGFR, KRAS, PIK3CA, BRAF, MET, EML4/ALK, RET and other mutations have been identified in pleural tumour biopsies and pleural fluid aspirates from MPE patients8, 9, 10, 11, 12, 13, 14, 15, 16.